397 related articles for article (PubMed ID: 12712008)
1. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
Yang L; Ng KY; Lillehei KO
Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
[TBL] [Abstract][Full Text] [Related]
2. Glioma immunology and immunotherapy.
Parney IF; Hao C; Petruk KC
Neurosurgery; 2000 Apr; 46(4):778-91; discussion 791-2. PubMed ID: 10764250
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell vaccines.
Yamanaka R; Kajiwara K
Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
[TBL] [Abstract][Full Text] [Related]
5. Principles of immunotherapy.
Liebelt BD; Finocchiaro G; Heimberger AB
Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based active specific immunotherapy for malignant glioma.
Parajuli P; Mathupala S; Mittal S; Sloan AE
Expert Opin Biol Ther; 2007 Apr; 7(4):439-48. PubMed ID: 17373896
[TBL] [Abstract][Full Text] [Related]
7. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
Lee Y; Bigner DD
Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
[TBL] [Abstract][Full Text] [Related]
8. Basic concepts in glioma immunology.
Parney IF
Adv Exp Med Biol; 2012; 746():42-52. PubMed ID: 22639158
[TBL] [Abstract][Full Text] [Related]
9. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
10. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
Akasaki Y; Black KL; Yu JS
Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
[TBL] [Abstract][Full Text] [Related]
11. T-cell immunotherapy for malignant glioma: toward a combined approach.
Dietrich PY; Dutoit V; Tran Thang NN; Walker PR
Curr Opin Oncol; 2010 Nov; 22(6):604-10. PubMed ID: 20739889
[TBL] [Abstract][Full Text] [Related]
12. [Dendritic cell therapy for malignant glioma].
Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
[TBL] [Abstract][Full Text] [Related]
13. Cellular immunotherapy for malignant gliomas.
Lin Y; Okada H
Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity and immunotherapy of brain tumors.
Prins RM; Liau LM
Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342
[TBL] [Abstract][Full Text] [Related]
15. Cell-Based Immunotherapy of Gliomas.
Everson RG; Antonios JP; Liau LM
Prog Neurol Surg; 2018; 32():90-100. PubMed ID: 29990977
[TBL] [Abstract][Full Text] [Related]
16. Dendritic-cell- and peptide-based vaccination strategies for glioma.
Yamanaka R
Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell vaccines and immunity in glioma patients.
Wheeler CJ; Black KL
Front Biosci; 2005 Sep; 10():2861-81. PubMed ID: 15970541
[TBL] [Abstract][Full Text] [Related]
18. Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy.
Chuntova P; Downey KM; Hegde B; Almeida ND; Okada H
Front Immunol; 2018; 9():3062. PubMed ID: 30740109
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell immunotherapy for malignant gliomas.
Luptrawan A; Liu G; Yu JS
Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]